Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Parenteral Pyronaridine and Artesunate
NCT05929157Phase 2Unknown
- Sponsor
- Centre de Recherches Médicales de Lambaréné
- Start
- Sep 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artesunate, pyronaridine in malaria, sponsored by Centre de Recherches Médicales de Lambaréné. Status: unknown.
02
Drugs
artesunatepyronaridine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05929157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05929157.